The Challenge of CMC Regulatory Compliance for Biopharmaceuticals and Other Biologics
An effective CMC regulatory compliance strategy for biologics and biopharmaceuticals can seem like a mystery. Through means of this 2nd edition, this no longer needs to occur. A great deal of thanks goes to two regulatory authorities – the United States Food and Drug Administration (FDA) and the E...
| Main Author: | |
|---|---|
| Corporate Author: | |
| Format: | Electronic eBook |
| Language: | English |
| Published: |
New York, NY :
Springer New York : Imprint: Springer,
2013.
|
| Edition: | 2nd ed. 2013. |
| Subjects: | |
| Online Access: | Full Text via HEAL-Link |
